Loading company…
QuadMedicine develops microneedle patch technology for vaccines, drugs and diagnostic devices.
QuadMedicine's medical microneedle platform includes patches, formulations, manufacturing equipment and testing methods for biologics, chemical drugs and diagnostics. Its pipeline includes candidates for vaccination, osteoporosis and alopecia. Based in Seongnam, South Korea, the company raised KRW 7 billion in pre-IPO funding in January 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in